SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-015408
Filing Date
2023-06-12
Accepted
2023-06-12 19:39:51
Documents
2
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4166
2 EX-24 DOCUMENT attachment1.htm EX-24 3960
  Complete submission text file 0000899243-23-015408.txt   9474
Mailing Address C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Quimi Daphne (Reporting) CIK: 0001543031 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41199 | Film No.: 231009879

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations